Frankfurt, Germany, November 8, 2017- SGCI is pleased to announce that we have begun assisting our client Beloni Group in its dual listing on the public market (regulated unofficial market) of the Frankfurt Stock Exchange. Beloni has reached an agreement with SGCI to appoint our company and its subsidiaries as advisors for the listing process. Our team of financial and consulting experts specializes in IPO services, financing, and mergers and acquisitions, and we will work with Beloni to ensure the smooth completion of the entire process. It is expected that the listing application will be submitted in the first quarter of 2018.

After completing the dual listing on the Frankfurt Stock Exchange, SGCI will assist our clients in conducting roadshows in Europe to raise funds and advise them on how to use these new funds to showcase existing business and explore new opportunities, such as collaborating with other leaders in the biopharmaceutical industry through joint ventures or investing in research and clinical trials of potential high growth new biomedical products.